Health
Pfizer’s COVID vaccine shows ‘robust’ results in early trial – Medical Xpress
(HealthDay)—A vaccine based on cutting-edge RNA gene technology showed promising potency against the new coronavirus in an early trial, scientists report.
by E.j. Mundell, Healthday Reporter (HealthDay)A vaccine based on cutting-edge RNA gene technology showed promising potency against the new coronavirus in an early trial, scientists report.
The vaccine candidatefor now just called BNT162b1″elicited a robust immune response in participants, which increased with dose level and with a second dose,” according to a news release from the journal Nature, which published the trial data on Aug. 12.
The early phase 1/2 trial was led by Dr. Judith Absal…
-
General15 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News24 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News22 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
Noosa News15 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial